These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36371868)

  • 1. 'Anxious fluctuators' a subgroup of Parkinson's disease with high anxiety and problematic on-off fluctuations.
    Pontone GM; Perepezko KM; Hinkle JT; Gallo JJ; Grill S; Leoutsakos JM; Mills KA; Weiss HD; Mari Z
    Parkinsonism Relat Disord; 2022 Dec; 105():62-68. PubMed ID: 36371868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wearing off: A complex phenomenon often poorly recognized in Parkinson's disease. A study with the WOQ-19 questionnaire.
    Pistacchi M; Gioulis M; Sanson F; Marsala SZ
    Neurol India; 2017; 65(6):1271-1279. PubMed ID: 29133700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease.
    Stacy M
    J Neural Transm (Vienna); 2010 Jul; 117(7):837-46. PubMed ID: 20563826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
    de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
    Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety and motor fluctuations in Parkinson's disease: a cross-sectional observational study.
    Leentjens AF; Dujardin K; Marsh L; Martinez-Martin P; Richard IH; Starkstein SE
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1084-8. PubMed ID: 22771284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ON-OFF Effects of Dopaminergic Therapy on Psychiatric Symptoms in Parkinson's Disease.
    Ganjavi H; MacDonald PA
    J Neuropsychiatry Clin Neurosci; 2015; 27(2):e134-9. PubMed ID: 25923857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.
    Delpont B; Lhommée E; Klinger H; Schmitt E; Bichon A; Fraix V; Castrioto A; Quesada JL; Pélissier P; Kistner A; Carnicella S; Lüscher C; Broussolle E; Pollak P; Thobois S; Krack P
    Mov Disord; 2017 Nov; 32(11):1566-1573. PubMed ID: 28737225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Fluctuations in Daytime Sleepiness and Motor and Non-Motor Symptoms in Parkinson's Disease.
    Höglund A; Hagell P; Broman JE; Pålhagen S; Sorjonen K; Fredrikson S; Svenningsson P
    Mov Disord Clin Pract; 2021 Jan; 8(1):44-50. PubMed ID: 33426158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Nonmotor Fluctuations Using a Diary in Advanced Parkinson's disease.
    Ossig C; Sippel D; Fauser M; Gandor F; Jost WH; Ebersbach G; Storch A
    J Parkinsons Dis; 2016 May; 6(3):597-607. PubMed ID: 27258695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study.
    Larsen JP; Karlsen K; Tandberg E
    Mov Disord; 2000 Sep; 15(5):826-9. PubMed ID: 11009186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putaminal Dopamine Turnover in de novo Parkinson's Disease Predicts Later Neuropsychiatric Fluctuations but Not Other Major Health Outcomes.
    Löhle M; Hermann W; Hausbrand D; Wolz M; Mende J; Beuthien-Baumann B; Oehme L; van den Hoff J; Kotzerke J; Reichmann H; Hermann A; Storch A
    J Parkinsons Dis; 2019; 9(4):693-704. PubMed ID: 31381528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metacognitions, anxiety, and distress related to motor fluctuations in Parkinson's disease.
    Brown RG; Fernie BA
    J Psychosom Res; 2015 Feb; 78(2):143-8. PubMed ID: 25311871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory-perceptual processing while walking.
    Ehgoetz Martens KA; Ellard CG; Almeida QJ
    Neuropsychologia; 2015 Dec; 79(Pt B):322-31. PubMed ID: 26004056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy.
    Stacy MA; Murck H; Kroenke K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):57-61. PubMed ID: 19793544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson's disease.
    Ehgoetz Martens KA; Ellard CG; Almeida QJ
    Eur J Neurosci; 2015 Aug; 42(4):2028-35. PubMed ID: 25899750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease.
    Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Schelosky L; Tison F; Rascol O
    JAMA Neurol; 2014 Jul; 71(7):884-90. PubMed ID: 24839938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor and non-motor wearing-off and its impact in the quality of life of patients with Parkinson's disease.
    Rodríguez-Violante M; Ospina-García N; Dávila-Avila NM; Cruz-Fino D; Cruz-Landero A; Cervantes-Arriaga A
    Arq Neuropsiquiatr; 2018 Aug; 76(8):517-521. PubMed ID: 30231124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiety Change After Dopamine Therapy in Parkinson Disease is Independent of Motor Improvement.
    Hinkle JT; Mills KA; Morrow CB; Pontone GM
    Am J Geriatr Psychiatry; 2024 Feb; 32(2):220-229. PubMed ID: 37867011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.